Mumps vaccine associated orchitis: Evidence supporting a potential immune-mediated mechanism

Vanessa Clifford1, Jane Wadsley, Bernard Jenner

  • 1Infectious Diseases Unit, Department of General Medicine & Murdoch Childrens Research Institute, Royal Children's Hospital Melbourne, Parkville, Victoria 3052, Australia. vanessa.clifford@rch.org.au

Vaccine
|January 21, 2010
PubMed

Insights

Three cases of orchitis occurred after the mumps-measles-rubella (MMR) vaccine, with two cases appearing within three days. Further research is needed to understand the cause of vaccine-related orchitis.

Area of Science:

  • Immunology
  • Virology
  • Pediatrics

Background:

  • Orchitis is a known complication of mumps infection, especially in post-pubertal males.
  • Mumps vaccination is rarely associated with orchitis.

Observation:

  • Three cases of orchitis following mumps-measles-rubella (MMR) vaccination were observed.
  • Two of these cases presented with symptom onset within three days post-vaccination.

Findings:

  • The reported cases contribute to the understanding of post-vaccine orchitis.
  • A review of existing literature indicates uncertainty surrounding the pathogenesis of vaccine-induced orchitis.

Implications:

  • These findings underscore the importance of continued surveillance for rare vaccine complications.
  • Further investigation into the mechanisms of post-vaccine orchitis is warranted to ensure vaccine safety.